找到约 24 条 “AM966” 相关结果 (用时 0.142 秒)
目录号 | 产品名称 | 中文名称 | 靶点 |
---|---|---|---|
M2144 | Topotecan hydrochloride | 盐酸拓扑替康;盐酸拓普替康;拓普替康 | Topoisomerase |
Hycamtin, NSC 609669 | |||
Topotecan HCl是一种拓扑异构酶I(Topoisomerase I)抑制剂,作用于MCF-7 Luc细胞和DU-145 Luc细胞,IC50分别为13 nM和2 nM。 | |||
M8992 | AM966 | AM966 | LPL Receptor |
AM966是一种有效的,选择性和口服活性的LPA(1)受体拮抗剂,可抑制小鼠博来霉素模型中的肺纤维化。 | |||
M11845 | ChemBridge-5219668 | ChemBridge化合物-5219668 | Screening Compounds and Building Blocks |
2-chloro-N-(6-methyl-2,3,4,9-tetrahydro-1H-carbazol-1-yl)acetamide (5219668) | |||
ChemBridge特有类药化合物/先导化合物-5219668,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M12828 | ChemBridge-6966147 | ChemBridge化合物-6966147 | Screening Compounds and Building Blocks |
2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-N-[2-(2-fluorophenyl)ethyl]acetamide (6966147) | |||
ChemBridge特有类药化合物/先导化合物-6966147,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M13267 | ChemBridge-29663452 | ChemBridge化合物-29663452 | Screening Compounds and Building Blocks |
3-ethyl-N-[(2-pyrazin-2-yl-1,3-thiazol-4-yl)methyl]-1H-indole-2-carboxamide (29663452) | |||
ChemBridge特有类药化合物/先导化合物-29663452,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M45765 | ChemBridge-5966524 | ChemBridge化合物-5966524 | Screening Compounds and Building Blocks |
2-({2-[(2-anilino-2-oxoethyl)thio]-1,3-benzothiazol-6-yl}amino)-2-oxoethyl diethyldithiocarbamate (5966524) | |||
ChemBridge特有类药化合物/先导化合物-5966524,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M45822 | ChemBridge-6119665 | ChemBridge化合物-6119665 | Screening Compounds and Building Blocks |
N-[3-(aminocarbonyl)-4-ethyl-5-methyl-2-thienyl]tetrahydro-2-furancarboxamide (6119665) | |||
ChemBridge特有类药化合物/先导化合物-6119665,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M45874 | ChemBridge-6269666 | ChemBridge化合物-6269666 | Screening Compounds and Building Blocks |
2-[(1-methyl-1H-imidazol-2-yl)thio]-N-(3-methylphenyl)acetamide (6269666) | |||
ChemBridge特有类药化合物/先导化合物-6269666,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M45913 | ChemBridge-6434966 | ChemBridge化合物-6434966 | Screening Compounds and Building Blocks |
5-hydroxy-2-{[(2-mesityl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl)carbonyl]amino}benzoic acid (6434966) | |||
ChemBridge特有类药化合物/先导化合物-6434966,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M46081 | ChemBridge-7196636 | ChemBridge化合物-7196636 | Screening Compounds and Building Blocks |
3-(4-fluorophenyl)-N-(2-methoxyphenyl)-1-phenyl-1H-pyrazole-4-carboxamide (7196636) | |||
ChemBridge特有类药化合物/先导化合物-7196636,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M46480 | ChemBridge-7966051 | ChemBridge化合物-7966051 | Screening Compounds and Building Blocks |
(4-{[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl]amino}phenyl)acetic acid (7966051) | |||
ChemBridge特有类药化合物/先导化合物-7966051,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M46481 | ChemBridge-7966545 | ChemBridge化合物-7966545 | Screening Compounds and Building Blocks |
2-fluoro-N-[(5-{[(4-oxo-3,4-dihydro-2-quinazolinyl)methyl]thio}-4-phenyl-4H-1,2,4-triazol-3-yl)methyl]benzamide (7966545) | |||
ChemBridge特有类药化合物/先导化合物-7966545,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M46679 | ChemBridge-8896633 | ChemBridge化合物-8896633 | Screening Compounds and Building Blocks |
2-(5-fluoro-1H-indol-3-yl)-N-(5-methylisoxazol-3-yl)-2-oxoacetamide (8896633) | |||
ChemBridge特有类药化合物/先导化合物-8896633,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M47008 | ChemBridge-9196626 | ChemBridge化合物-9196626 | Screening Compounds and Building Blocks |
2-(4-fluorophenoxy)butanamide (9196626) | |||
ChemBridge特有类药化合物/先导化合物-9196626,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M47352 | ChemBridge-13496694 | ChemBridge化合物-13496694 | Screening Compounds and Building Blocks |
N-(1-methylbutyl)-3-({[(5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl]amino}sulfonyl)benzamide (13496694) | |||
ChemBridge特有类药化合物/先导化合物-13496694,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M47887 | ChemBridge-34499661 | ChemBridge化合物-34499661 | Screening Compounds and Building Blocks |
N-[(trans-3-hydroxycyclobutyl)(pyridin-2-yl)methyl]-4-(piperidin-1-ylmethyl)benzamide (34499661) | |||
ChemBridge特有类药化合物/先导化合物-34499661,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M47901 | ChemBridge-35089662 | ChemBridge化合物-35089662 | Screening Compounds and Building Blocks |
3-[(3-ethoxypropanoyl)amino]-N-(3-methoxyphenyl)benzamide (35089662) | |||
ChemBridge特有类药化合物/先导化合物-35089662,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M48570 | ChemBridge-62835966 | ChemBridge化合物-62835966 | Screening Compounds and Building Blocks |
N,1-dimethyl-N-[4-(1H-pyrazol-1-yl)benzyl]-4,5,6,7-tetrahydro-1H-indazole-3-carboxamide (62835966) | |||
ChemBridge特有类药化合物/先导化合物-62835966,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M48718 | ChemBridge-69666444 | ChemBridge化合物-69666444 | Screening Compounds and Building Blocks |
methyl 6-[({[(4-ethyl-1,3-thiazol-2-yl)methyl]amino}carbonyl)amino]-3,4-dihydroquinoline-1(2H)-carboxylate (69666444) | |||
ChemBridge特有类药化合物/先导化合物-69666444,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M49255 | ChemBridge-94966566 | ChemBridge化合物-94966566 | Screening Compounds and Building Blocks |
3-(4,6-dimethyl-2-oxopyrimidin-1(2H)-yl)-N-[(5-isobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-methylpropanamide (94966566) | |||
ChemBridge特有类药化合物/先导化合物-94966566,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M49285 | ChemBridge-96675668 | ChemBridge化合物-96675668 | Screening Compounds and Building Blocks |
3-(1H-indol-5-yl)-N-methyl-N-(tetrahydro-2H-pyran-2-ylmethyl)benzamide (96675668) | |||
ChemBridge特有类药化合物/先导化合物-96675668,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M49978 | ChemBridge-41951966 | ChemBridge化合物-41951966 | Screening Compounds and Building Blocks |
1-{[1'-(2-phenylethyl)-1,4'-bipiperidin-3-yl]carbonyl}azetidin-3-amine (41951966) | |||
ChemBridge特有类药化合物/先导化合物-41951966,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M20630 | ex229 (compound 991) | ex229 (compound 991) | AMPK |
EX229 (compound 991)是一种有效的AMPK激活剂,其激活AMPK的效力比A769662高5-10倍。 | |||
M28491 | MRT199665 | MRT199665 | Salt-inducible Kinase |
MRT199665 是一种有效的,ATP竞争性的,选择性 MARK/SIK/AMPK 抑制剂,对 MARK1/MARK2/MARK3/MARK14,AMPKα1/AMPKα2 和 SIK1/SIK2/SIK3 的 IC50 分别为 2/2/3/2 nM,10/10 nM 和 110/12/43 nM。MRT199665 作用于 MEF2C 激活的人急性髓性白血病 (AML) 细胞,引起凋亡 (apoptosis)。MRT199665 抑制 SIK 底物 CRTC3 磷酸化 (在 S370 位点)。 |
产品仅供科学研究或药证申报的用途使用,不为任何个人或者非科研性质的其他用途提供服务。
Copyright © 2010-2022 AbMole版权所有 沪ICP备16047849号 沪公网安备 31011502012228号